about
Off-label use of calcium channel blockers as tocolytic agent. CNGOF Workgroup (Short text)Efficiency and tolerance of calcium channel blockers as first-line tocolysisShoulder dystocia: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF).French experience of 2009 A/H1N1v influenza in pregnant women.Determinants of non-vaccination against pandemic 2009 H1N1 influenza in pregnant women: a prospective cohort study.Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy.Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.Individual and organisational determinants associated with maintenance tocolysis in the management of preterm labour: a multilevel analysisInduction of labor and risk of postpartum hemorrhage in low risk parturients.Prognostic value of umbilical and cerebral Doppler in fetal growth restriction: comparison of dichorionic twins and singletons.Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.[Management of shoulder dystocia].[Shoulder dystocia: Guidelines for clinical practice--Short text].Duration of Expulsive Efforts and Risk of Postpartum Hemorrhage in Nulliparous Women: A Population-Based StudyRoutine third trimester ultrasound: what is the evidence?Imaging in the management of abdominal pregnancy: a case report and review of the literature.Ultrasound assessment of the prognosis in triplet pregnancies.Prolonged and post-term pregnancies: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF).Stabilising the caesarean rate: which target population?Anesthetic and Obstetrical Factors Associated With the Effectiveness of Epidural Analgesia for Labor Pain Relief: An Observational Population-Based Study.Lateral asymmetric decubitus position for the rotation of occipito-posterior positions: multicenter randomized controlled trial EVADELA.Elective induction of labour and maternal request: a national population-based study.When to stop pushing: effects of duration of second-stage expulsion efforts on maternal and neonatal outcomes in nulliparous women with epidural analgesia.[Risk of perinatal complication and egg donation: Role of resorting to cross-border care?][Predictive factors of 2-month postpartum anal incontinence among patients with an obstetrical anal sphincter injury].Oocyte donation recipients of very advanced age: perinatal complications for singletons and twins.Initial Preference for Labor Without Neuraxial Analgesia and Actual Use: Results from a National Survey in France.[Episiotomy in France in 2010: Variations according to obstetrical context and place of birth].Continued pregnancy and vaginal delivery after 32 weeks of gestation for monoamniotic twins.Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells.[Maternal effects of prolonged expulsive efforts].CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus.Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings.[Nifedipine or nicardipine in management of threatened preterm delivery: an observational population-based study].[Perineal consequences according to obstetric practices: A comparative study here and elsewhere, Canada and France].Manual rotation to decrease operative delivery in posterior or transverse positions.Potential avoidability of planned cesarean sections in a French national database.Obstetric interventions for low-risk pregnant women in France: do maternity unit characteristics make a difference?Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.Maternal and neonatal outcomes of successful Kielland's rotational forceps delivery.
P50
Q27024201-76171270-772B-484C-BC32-6250EE6EF83EQ28086854-EA9A5FE1-ED65-4231-B5D5-0D00E75141EDQ30249529-D8711E47-A547-4A60-B02C-72C95A070363Q30395018-2CEE87B8-26FE-40D1-BC16-9CD95685FBB4Q30404091-FCD48D3F-A84D-4676-902C-7C18DACD55EEQ33416344-48153737-E685-4633-8864-64951BEDF0A4Q34500006-7AB7E5E7-29C0-4C5C-9B15-2D26ADDA29CEQ34524997-1D6DDC4C-9FB4-4860-9A89-0F50F82A0F40Q34575756-BCD12A0F-C7CC-443B-8F8F-785201314A75Q35393911-CC88B694-0264-4A55-8ADE-13DF4AA0EC38Q35662691-046254AB-2862-4CAE-9722-1FFE8AAE1FA4Q35830989-1FAACEB8-7DFD-4FC5-BDFF-347342CEA1D9Q35833889-B63FAC0B-E780-48B1-B722-AD5A71AFDF71Q36267951-14315C16-8CBF-45F8-88D9-980932A85084Q37078492-1B5B22E8-271A-4BC7-BF23-D1BAF5EE63A4Q37390042-C9E3F0FD-A2BD-4C02-8696-E198F0F89D38Q37398915-F4D7D409-E4B2-46DC-BE4E-9E272F3592F2Q38084014-4640A3A8-57E0-4923-98A7-34AE2D5C6373Q39095758-410B8701-BAD7-4C98-8DF6-62ACE3927131Q39164291-291E80EF-A647-4FAE-A91F-0E2A1F42C866Q39724119-C8A06E68-8A64-4F1E-AD4F-E03D74A830F3Q40264836-029809A4-29B7-48E6-9B76-E1F01BA7027EQ40378574-9A2299D0-B6E3-4601-B869-E5D4176FC54CQ40525851-FA261BF8-0C81-4424-B16D-307D440CC8C5Q40525906-926CFD51-DE87-4986-ABFD-29F3B08961D8Q40540998-A7B8529B-0B3A-4B24-8CF9-AF67625B37F3Q40824044-D18602A9-A338-41F6-9FBD-44A19C81491AQ40842939-0CF0324A-73AA-4AF2-A96B-6BD43EBDDA29Q41261777-7D489696-D357-4297-962D-123401D0DCE6Q41341895-2405AEB8-2ED9-4F43-902C-674279090350Q41438316-3336A580-8BD6-48C0-A91E-D9899E1967DFQ42213414-03B681D8-656C-4EFF-8AFD-ECE5DFB8A3F6Q42235919-624F9ECF-1836-417E-B674-F763633EE3CBQ42971510-3806BF08-2E7E-4CB9-BFBC-7F55E98235EFQ43713387-1DF6E11A-1BA2-4C45-B397-83BE7ABD397CQ43961605-A3A68050-429B-4952-B2BF-0A93973E72D5Q44794750-E88A5EF9-1195-4338-A3D2-02480299EA8AQ44831158-A0725E3A-A3C5-4DDC-99EA-2A16C0C54CECQ44879522-770066C5-5BE3-4014-B3C5-7C778643A66EQ44934929-02461B9F-DFA1-4E11-8A3E-9A34D9878D05
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Camille Le Ray
@ast
Camille Le Ray
@en
Camille Le Ray
@es
Camille Le Ray
@nl
Camille Le Ray
@sl
type
label
Camille Le Ray
@ast
Camille Le Ray
@en
Camille Le Ray
@es
Camille Le Ray
@nl
Camille Le Ray
@sl
prefLabel
Camille Le Ray
@ast
Camille Le Ray
@en
Camille Le Ray
@es
Camille Le Ray
@nl
Camille Le Ray
@sl
P108
P106
P108
P21
P31
P496
0000-0003-0891-1063